AddOn

NEW ORLEANS — Adjunctive cariprazine (Vraylar) was linked with a reduction in depressive symptoms for patients with major depressive disorder (MDD), who had an inadequate response to current therapy, according to a phase III study. When added to a first-line antidepressant, 1.5 mg of once-daily cariprazine resulted in significantly greater […]